XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses        
Research and development $ 16,520 $ 7,931 $ 34,036 $ 23,245
General and administrative 3,990 3,267 11,845 9,417
Total operating expenses 20,510 11,198 45,881 32,662
Loss from operations (20,510) (11,198) (45,881) (32,662)
Other income, net 1,042 849 2,485 1,962
Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds 96,439 443 51,829 (55,738)
Net income (loss) 76,971 (9,906) 8,433 (86,438)
Net income (loss) attirbutable to common shares - basic $ 54,429 $ (9,906) $ 5,551 $ (86,438)
Basic net income (loss) per common share $ 1.05 $ (0.33) $ 0.13 $ (3.79)
Weighted-average number of shares outstanding, Basic 51,945,920 29,974,400 41,443,049 22,813,085
Net income (loss) attributable to common shares - diluted $ (17,504) $ (9,906) $ (61,086) $ (86,438)
Basic net income (loss) per common share $ (0.32) $ (0.33) $ (1.42) $ (3.79)
Weighted-average number of shares outstanding, Diluted 55,478,342 29,974,400 43,106,746 22,813,085